Therapeutic role of Panchakarma in non-alcoholic fatty liver disease: an integrative perspective

Introduction

Non-alcoholic fatty liver disease (NAFLD) is a progressive metabolic liver disorder characterized by excessive fat accumulation in hepatocytes in the absence of significant alcohol intake. It ranges from simple steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis, and hepatocellular carcinoma. Its pathogenesis is multifactorial, involving insulin resistance, dyslipidemia, oxidative stress, altered gut microbiota, and chronic low-grade inflammation.

In modern medicine, NAFLD is strongly associated with metabolic syndrome, obesity, and type 2 diabetes mellitus. Current management primarily includes lifestyle modification such as calorie restriction, dietary control, and physical activity, as no definitive pharmacological therapy is universally effective.

In Ayurveda, NAFLD can be correlated with Yakrit Roga and Medoroga, arising due to Agnimandya, Ama formation, Kapha–Pitta imbalance, and Meda Dhatu dushti. Sedentary lifestyle, improper diet, and disturbed digestion lead to Srotorodha and hepatic lipid accumulation, resembling fatty liver pathology.

Ayurvedic concept of NAFLD (Yakrit–Medoroga correlation)

Yakrit is considered a key organ of Raktadhatu and Meda metabolism regulation. In NAFLD, impaired Agni leads to Ama production, which obstructs metabolic channels and results in Meda accumulation in the liver. Classical texts describe Kapha–Pitta vitiation as central to this pathology, along with dietary indiscretion, inactivity, and metabolic sluggishness.

Role of Panchakarma in NAFLD

Panchakarma is a detoxification and rejuvenation therapy aimed at eliminating vitiated Doshas, restoring Agni, and correcting metabolic imbalance. In NAFLD, it addresses core pathology involving Kapha–Pitta aggravation and Meda accumulation through systemic cleansing and metabolic restoration.

Purva karma (preparatory procedures):

• Deepana–pachana (metabolic activation)

Deepana and Pachana therapies enhance Agni and digest Ama using formulations such as Trikatu and Chitrakadi preparations. These improve digestion, reduce metabolic toxins, and prepare the body for detoxification.

• Snehana (oleation therapy):

Internal and external oleation using medicated ghee or oils helps mobilize lipid deposits and loosens deeply seated toxins. It improves fat metabolism and supports bile secretion, aiding hepatic lipid clearance.

• Swedana (sudation therapy):

Swedana liquefies accumulated Doshas and enhances circulation and metabolic activity. Steam-based therapies improve sweating and facilitate removal of metabolic waste through skin and peripheral channels.

Pradhana karma (main Panchakarma therapies):

• Virechana (therapeutic purgation):

Virechana is the primary therapy for Pitta–Kapha disorders such as NAFLD. It eliminates excess Pitta and metabolic toxins via the gastrointestinal tract. Common formulations include Avipattikara Churna and Trivrit-based preparations. Clinically, it is associated with improvement in liver enzymes and lipid profiles, indicating reduced hepatic steatosis.

• Basti (medicated enema therapy):

Basti regulates Vata, which governs metabolic and catabolic processes. Lekhana Basti formulations help reduce Meda accumulation and improve gut–liver axis function. Herbal enemas also influence gut microbiota, thereby improving lipid metabolism and reducing systemic inflammation.

• Raktamokshana (bloodletting therapy):

Raktamokshana is indicated in Pitta-dominant or congestive hepatic conditions. It helps reduce localized inflammation and improves microcirculation, supporting hepatic detoxification in selected cases.

• Nasya and abhyanga (adjunct therapies):

Nasya and Abhyanga support systemic relaxation, stress reduction, and improved circulation. These therapies indirectly contribute to metabolic balance by modulating neuroendocrine and lymphatic functions.

Paschat karma (post-procedure regimen):

Samsarjana Krama involves gradual dietary reintroduction starting from light liquid diets to solid foods. This restores Agni, stabilizes digestion, and prevents recurrence of Ama and metabolic overload.

Rasayana therapy (rejuvenation phase):

Rasayana therapy promotes hepatic regeneration and metabolic recovery using herbs such as Guduchi, Bhumyamalaki, Punarnava, Amalaki, and Triphala. These exhibit antioxidant, anti-inflammatory, hepatoprotective, and lipid-lowering effects, supporting long-term liver health.

Mechanistic summary of Panchakarma in NAFLD

Panchakarma acts through multiple integrated mechanisms including Agni restoration, Dosha detoxification, Srotoshodhana (channel purification), Meda reduction, and hepatic rejuvenation. It improves lipid metabolism, reduces oxidative stress, and enhances hepatocellular function, thereby addressing both cause and manifestation of NAFLD.

Therapeutic Significance of Panchakarma in NAFLD

Conclusion

Panchakarma offers a comprehensive Ayurvedic approach for NAFLD management by targeting metabolic dysfunction, hepatic fat accumulation, and systemic inflammation. When combined with dietary regulation and Rasayana therapy, it provides a holistic strategy for prevention, treatment, and long-term metabolic restoration in Yakrit-related disorders.

References:

1. Sahu P, Zala M, Saini N, Koodur S, Singh T. Role of Panchakarma and Ahara Parivarjana in Non-Alcoholic Fatty Liver Disease (Yakrit Roga). J Ayu Int Med Sci. 2026;11(2):281-291. DOI:10.21760/jaims.11.2.44. https://jaims.in/jaims/article/download/5440/9906?inline=1